Regal Investment Advisors LLC grew its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 3.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,111 shares of the company’s stock after acquiring an additional 1,319 shares during the quarter. Regal Investment Advisors LLC’s holdings in Cardinal Health were worth $1,748,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of CAH. Dimensional Fund Advisors LP boosted its holdings in shares of Cardinal Health by 41.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,447,058 shares of the company’s stock valued at $109,144,000 after buying an additional 720,871 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Cardinal Health by 5.4% in the 4th quarter. Geode Capital Management LLC now owns 4,155,931 shares of the company’s stock valued at $185,121,000 after buying an additional 213,970 shares during the period. Municipal Employees Retirement System of Michigan acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $364,000. Advisory Services Network LLC boosted its holdings in shares of Cardinal Health by 15.1% in the 4th quarter. Advisory Services Network LLC now owns 1,497 shares of the company’s stock valued at $67,000 after buying an additional 196 shares during the period. Finally, First Hawaiian Bank boosted its holdings in shares of Cardinal Health by 5.4% in the 1st quarter. First Hawaiian Bank now owns 4,317 shares of the company’s stock valued at $208,000 after buying an additional 222 shares during the period. 89.23% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have recently commented on the stock. Zacks Investment Research lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Tuesday, April 9th. ValuEngine raised shares of Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Thursday, May 9th. Finally, Guggenheim began coverage on shares of Cardinal Health in a report on Wednesday, April 17th. They issued a “neutral” rating and a $51.00 price target for the company. Three equities research analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company. The stock has an average rating of “Hold” and an average target price of $54.11.
Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, May 9th. The company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.16. The firm had revenue of $35.23 billion for the quarter, compared to analyst estimates of $35.09 billion. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.39 earnings per share. On average, research analysts expect that Cardinal Health Inc will post 5.11 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, July 15th. Shareholders of record on Monday, July 1st were paid a dividend of $0.4811 per share. This represents a $1.92 dividend on an annualized basis and a yield of 4.57%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend was Friday, June 28th. Cardinal Health’s payout ratio is presently 38.40%.
Cardinal Health Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Article: Can systematic risk be avoided?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.